MétaCan
Menu
Back to cohort
Record W4400408647 · doi:10.1016/j.jhepr.2024.101168

Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis

2024· article· en· W4400408647 on OpenAlexafffundabout
Surain B. Roberts, Woo Jin Choi, Lawrence Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark G. Swain, Dusanka Grbic, Hin Hin Ko, Kevork Peltekian, Lusine Abrahamyan, Monika Lamba Saini, Kattleya Tirona, Bishoi Aziz, Ellina Lytvyak, Pietro Invernizzi, Cyriel Y. Ponsioen, Tony Bruns, Nora Cazzagon, Keith D. Lindor, George Ν. Dalekos, Nikolaos Gatselis, Xavier Verhelst, Annarosa Floreani, Christophe Corpechot, Marlyn J. Mayo, Cynthia Levy, María‐Carlota Londoño, Pier Maria Battezzati, Albert Parés, Frederik Nevens, Adriaan van der Meer, Kris V. Kowdley, Palak Trivedi, Ana Lleò, Douglas Thorburn, Marco Carbone, Nazia Selzner, Aliya Gulamhusein, Harry L.A. Janssen, Aldo J. Montaño‐Loza, Andrew L. Mason, Gideon M. Hirschfield, Bettina E. Hansen

Bibliographic record

VenueJHEP Reports · 2024
Typearticle
Languageen
FieldMedicine
TopicLiver Diseases and Immunity
Canadian institutionsUniversity of AlbertaDalhousie UniversityUniversity of British ColumbiaUniversity of CalgaryUniversity of OttawaWestern UniversityUniversity of TorontoUniversité de SherbrookeQueen's UniversityToronto General HospitalUniversity Health NetworkUniversité de MontréalUniversity of SaskatchewanSt. Michael's Hospital
FundersAllerganGrifolsIpsenNovo NordiskSwedish Orphan BiovitrumEuropean Association for the Study of the LiverVir BiotechnologyIntercept PharmaceuticalsPfizerIncyteBristol-Myers SquibbDr. Falk PharmaCSL BehringUltragenyx PharmaceuticalCanadian Liver FoundationCelgenePSC Partners Seeking a CureGilead SciencesAmerican Association for the Study of Liver DiseasesKowa CompanySanofiGenesis PharmaLifeArcFalk Foundation
KeywordsUrsodeoxycholic acidMedicineInternal medicineLiver transplantationPrimary biliary cirrhosisGastroenterologyAlkaline phosphataseLiver diseaseCohortBilirubinTransplantationBiology

Abstract

fetched live from OpenAlex

Background & Aims: Biochemical response to ursodeoxycholic acid (UDCA) therapy is associated with good prognosis in people living with primary biliary cholangitis (PBC). Biochemical response is typically assessed early in disease and it is not known what proportion of patients lose previously attained biochemical response, nor whether this impacts long-term liver transplant (LT)-free survival. Methods: We identified all UDCA-treated patients with PBC from the Canadian Network for Autoimmune Liver disease with biochemical measurements at 1 year, and evaluated their liver biochemistry over time. Inadequate biochemical response was defined as serum alkaline phosphatase ≥1.67x the upper limit of normal or abnormal serum total bilirubin at 1 year of UDCA therapy and all time points thereafter. Multistate Markov models were used to estimate transition rates between biochemical response states and from each state to LT or death. Results were validated in an external cohort (GLOBAL PBC registry). Results: A total of 823 patients from eight centers were included. Mean age at diagnosis was 53 years, 91% were female, 33% had inadequate biochemical response to UDCA at 1 year (n = 269). Patients who retained initial adequate response had lower rates of LT or death compared to patients who subsequently lost response (relative rate 0.102, 95% CI 0.047-0.223). Patients who regained adequate response had lower rates than patients who did not (0.016, 95% CI 0.001-0.568), and patients who lost response once more (0.010, 95% CI 0.001-0.340). Patients who regained adequate response for a third time also had lower rates than patients who did not (0.151, 95% CI 0.040-0.566). Analyses in the GLOBAL PBC registry (n = 2,237) validated these results. Conclusion: Loss of biochemical response at any time is associated with heightened risks of LT or death in people living with PBC. Achievement of biochemical response is an important goal throughout follow-up, regardless of biochemical response profile early in therapy. Impact and implications: Early biochemical response to ursodeoxycholic acid is associated with good prognosis in patients with primary biliary cholangitis (PBC). Our work demonstrates that patients with PBC transition between biochemical response states over time, and that these transitions correspond with changes in risk of liver transplantation or death. Clinicians should re-evaluate risk and optimize treatment decisions for patients with PBC throughout follow-up, regardless of early biochemical response to therapy.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.011
Threshold uncertainty score0.412

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.005
GPT teacher head0.230
Teacher spread0.225 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations15
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueJHEP ReportsSame topicLiver Diseases and ImmunityFrench-language works237,207